Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10. (Q45987459)
Jump to navigation
Jump to search
scientific article published on 30 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10. |
scientific article published on 30 May 2009 |
Statements
1 reference
Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10. (English)
1 reference
Takashi Mizuma
1 reference
30 May 2009
1 reference
378
1 reference
1-2
1 reference
140-141
1 reference
Identifiers
1 reference
1 reference